Towards the Application of Human Defensins as Antivirals |
Park, Mee Sook
(Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University)
Kim, Jin Il (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Lee, Ilseob (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Park, Sehee (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Bae, Joon-Yong (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) Park, Man-Seong (Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University) |
1 | Vernieri, E., Valle, J., Andreu, D. and de la Torre, B. G. (2014) An optimized Fmoc synthesis of human defensin 5. Amino Acids 46, 395- 400. DOI |
2 | Kluver, E., Schulz-Maronde, S., Scheid, S., Meyer, B., Forssmann, W. G. and Adermann, K. (2005) Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 44, 9804-9816. DOI |
3 | Kota, S., Sabbah, A., Chang, T. H., Harnack, R., Xiang, Y., Meng, X. and Bose, S. (2008) Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J. Biol. Chem. 283, 22417-22429. DOI |
4 | Krammer, F. and Palese, P. (2013) Influenza virus hemagglutinin stalkbased antibodies and vaccines. Curr. Opin. Virol. 3, 521-530. DOI |
5 | Krammer, F., Palese, P. and Steel, J. (2015) Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr. Top. Microbiol. Immunol. 386, 301-321. |
6 | Kurane, I. and Ennis, F. A. (1988) Production of interferon alpha by dengue virus-infected human monocytes. J. Gen. Virol. 69, 445- 449. DOI |
7 | Kurosawa, S., Ohta, M., Hayakawa, M., Kamino, Y., Abiko, Y. and Sasahara, H. (2002) Characterization of rat monoclonal antibodies against human beta-defensin-2. Hybrid. Hybridomics 21, 359-363. DOI |
8 | Lehrer, R. I. (2004) Primate defensins. Nat. Rev. Microbiol. 2, 727-738. DOI |
9 | Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T. and Selsted, M. E. (1989) Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Invest. 84, 553-561. DOI |
10 | Lehrer, R. I., Jung, G., Ruchala, P., Andre, S., Gabius, H. J. and Lu, W. (2009) Multivalent binding of carbohydrates by the human alphadefensin, HD5. J. Immunol. 183, 480-490. DOI |
11 | Lehrer, R. I. and Lu, W. (2012) -Defensins in human innate immunity. Immunol. Rev. 245, 84-112. DOI |
12 | Wu, Z., Hoover, D. M., Yang, D., Boulegue, C., Santamaria, F., Oppenheim, J. J., Lubkowski, J. and Lu, W. (2003a) Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. U.S.A. 100, 8880-8885. DOI |
13 | Wu, Z., Li, X., Ericksen, B., de Leeuw, E., Zou, G., Zeng, P., Xie, C., Li, C., Lubkowski, J., Lu, W. Y. and Lu W. (2007) Impact of pro segments on the folding and function of human neutrophil alphadefensins. J. Mol. Biol. 368, 537-549. DOI |
14 | Wu, Z., Prahl, A., Powell, R., Ericksen, B., Lubkowski, J. and Lu, W. (2003b) From pro defensins to defensins: synthesis and characterization of human neutrophil pro alpha-defensin-1 and its mature domain. J. Pept. Res. 62, 53-62. DOI |
15 | Wykes, M., Pombo, A., Jenkins, C. and MacPherson, G. G. (1998) Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161, 1313-1319. |
16 | Xu, Z., Peng, L., Zhong, Z., Fang, X. and Cen, P. (2006a) High-level expression of a soluble functional antimicrobial peptide, human beta-defensin 2, in Escherichia coli. Biotechnol. Prog. 22, 382-386. DOI |
17 | Xu, Z., Zhong, Z., Huang, L., Peng, L., Wang, F. and Cen, P. (2006b) High-level production of bioactive human beta-defensin-4 in Escherichia coli by soluble fusion expression. Appl. Microbiol. Biotechnol. 72, 471-479. DOI |
18 | Yang, D., Biragyn, A., Kwak, L. W. and Oppenheim, J. J. (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23, 291-296. DOI |
19 | Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schroder, J. M., Wang, J. M., Howard, O. M. and Oppenheim, J. J. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528. DOI |
20 | Mangoni, M. L., McDermott, A. M. and Zasloff, M. (2016) Antimicrobial peptides and wound healing: biological and therapeutic considerations. Exp. Dermatol. 25, 167-173. DOI |
21 | Megjugorac, N. J., Young, H. A., Amrute, S. B., Olshalsky, S. L. and Fitzgerald-Bocarsly, P. (2004) Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. J. Leukoc. Biol. 75, 504-514. DOI |
22 | Menendez, A. and Brett Finlay, B. (2007) Defensins in the immunology of bacterial infections. Curr. Opin. Immunol. 19, 385-391. DOI |
23 | Mohan, T., Mitra, D. and Rao, D. N. (2014) Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1. Immunol. Res. 58, 139-153. DOI |
24 | Moon, S. K. and Lim, D. J. (2015) Intratympanic gene delivery of antimicrobial molecules in otitis media. Curr. Allergy Asthma Rep. 15, 14. DOI |
25 | Morgan, A. J. and Parker, S. (2007) Translational mini-review series on vaccines: the Edward Jenner Museum and the history of vaccination. Clin. Exp. Immunol. 147, 389-394. DOI |
26 | Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. J. and Kwak, L. W. (2002) Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298, 1025-1029. DOI |
27 | Jarczak, J., Kosciuczuk, E. M., Lisowski, P., Strzalkowska, N., Jozwik, A., Horbanczuk, J., Krzyzewski, J., Zwierzchowski, L. and Bagnicka, E. (2013) Defensins: natural component of human innate immunity. Hum. Immunol. 74, 1069-1079. DOI |
28 | Jiang, D., Weidner, J. M., Qing, M., Pan, X. B., Guo, H., Xu, C., Zhang, X., Birk, A., Chang, J., Shi, P. Y., Block, T. M. and Guo, J. T. (2010) Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J. Virol. 84, 8332-8341. DOI |
29 | Jiang, Y., Yang, D., Li, W., Wang, B., Jiang, Z. and Li, M. (2012) Antiviral activity of recombinant mouse -defensin 3 against influenza A virus in vitro and in vivo. Antivir. Chem. Chemother. 22, 255-262. DOI |
30 | Ju, S. M., Goh, A. R., Kwon, D. J., Youn, G. S., Kwon, H. J., Bae, Y. S., Choi, S. Y. and Park, J. (2012) Extracellular HIV-1 Tat induces human beta-defensin-2 production via NF-kappaB/AP-1 dependent pathways in human B cells. Mol. Cells 33, 335-341. DOI |
31 | Mousa, J. J., Kose, N., Matta, P., Gilchuk, P. and Crowe, J. E., Jr. (2017) A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Nat. Microbiol. 2, 16271. DOI |
32 | Neumann, G. and Kawaoka, Y. (2011) The first influenza pandemic of the new millennium. Influenza Other Respir. Viruses 5, 157-166. DOI |
33 | Nguyen, E. K., Nemerow, G. R. and Smith, J. G. (2010) Direct evidence from single-cell analysis that human -defensins block adenovirus uncoating to neutralize infection. J. Virol. 84, 4041-4049. DOI |
34 | Bustos-Arriaga, J., Garcia-Machorro, J., Leon-Juarez, M., Garcia- Cordero, J., Santos-Argumedo, L., Flores-Romo, L., Mendez-Cruz, A. R., Juarez-Delgado, F. J. and Cedillo-Barron, L. (2011) Activation of the innate immune response against DENV in normal nontransformed human fibroblasts. PLoS Negl. Trop. Dis. 5, e1420. DOI |
35 | Boman, H. G. (2003) Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254, 197-215. DOI |
36 | Brandt, C. R., Akkarawongsa, R., Altmann, S., Jose, G., Kolb, A. W., Waring, A. J. and Lehrer, R. I. (2007) Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis. Invest. Ophthalmol. Vis. Sci. 48, 5118-5124. DOI |
37 | Brass, A. L., Huang, I. C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., Adams, D. J., Xavier, R. J., Farzan, M. and Elledge, S. J. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254. DOI |
38 | Carrat, F. and Flahault, A. (2007) Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852-6862. DOI |
39 | Castaneda-Sanchez, J. I., Dominguez-Martinez, D. A., Olivar-Espinosa, N., Garcia-Perez, B. E., Lorono-Pino, M. A., Luna-Herrera, J. and Salazar, M. I. (2016) Expression of antimicrobial peptides in human monocytic cells and neutrophils in response to dengue virus type 2. Intervirology 59, 8-19. DOI |
40 | Chang, T. L., Francois, F., Mosoian, A. and Klotman, M. E. (2003) CAFBiomol mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J. Virol. 77, 6777-6784. DOI |
41 | Pollara, J., Easterhoff, D. and Fouda, G. G. (2017) Lessons learned from human HIV vaccine trials. Curr. Opin. HIV AIDS 12, 216-221. DOI |
42 | Dowd, K. A., DeMaso, C. R. and Pierson, T. C. (2015) Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing. MBio 6, e01559-15. |
43 | Demirkhanyan, L. H., Marin, M., Padilla-Parra, S., Zhan, C., Miyauchi, K., Jean-Baptiste, M., Novitskiy, G., Lu, W. and Melikyan, G. B. (2012) Multifaceted mechanisms of HIV-1 entry inhibition by human -defensin. J. Biol. Chem. 287, 28821-28838. DOI |
44 | Diamond, M. S. and Harris, E. (2001) Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology 289, 297-311. DOI |
45 | Doss, M., White, M. R., Tecle, T., Gantz, D., Crouch, E. C., Jung, G., Ruchala, P., Waring, A. J., Lehrer, R. I. and Hartshorn, K. L. (2009) Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J. Immunol. 182, 7878-7887. DOI |
46 | Gounder, A. P., Myers, N. D., Treuting, P. M., Bromme, B. A., Wilson, S. S., Wiens, M. E., Lu, W., Ouellette, A. J., Spindler, K. R., Parks, W. C. and Smith, J. G. (2016) Defensins potentiate a neutralizing antibody response to enteric viral infection. PLoS Pathog. 12, e1005474. DOI |
47 | Garcia, J. R., Krause, A., Schulz, S., Rodriguez-Jimenez, F. J., Kluver, E., Adermann, K., Forssmann, U., Frimpong-Boateng, A., Bals, R. and Forssmann, W. G. (2001) Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 15, 1819-1821. DOI |
48 | Gerlier, D. and Lyles, D. S. (2011) Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol. Mol. Biol. Rev. 75, 468-490 (second page of table of contents). DOI |
49 | Gonzalez, S. F., Lukacs-Kornek, V., Kuligowski, M. P., Pitcher, L. A., Degn, S. E., Kim, Y. A., Cloninger, M. J., Martinez-Pomares, L., Gordon, S., Turley, S. J. and Carroll, M. C. (2010) Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes. Nat. Immunol. 11, 427- 434. |
50 | Gounder, A. P., Wiens, M. E., Wilson, S. S., Lu, W. and Smith, J. G. (2012) Critical determinants of human -defensin 5 activity against non-enveloped viruses. J. Biol. Chem. 287, 24554-24562. DOI |
51 | Gropp, R., Frye, M., Wagner, T. O. and Bargon, J. (1999) Epithelial defensins impair adenoviral infection: implication for adenovirusmediated gene therapy. Hum. Gene Ther. 10, 957-964. DOI |
52 | Haasbach, E., Droebner, K., Vogel, A. B. and Planz, O. (2011) Lowdose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo. J. Interferon Cytokine Res. 31, 515-525. DOI |
53 | Klotman, M. E. and Chang, T. L. (2006) Defensins in innate antiviral immunity. Nat. Rev. Immunol. 6, 447-456. DOI |
54 | Kawai, T. and Akira, S. (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650. DOI |
55 | Kernbauer, E., Ding, Y. and Cadwell, K. (2014) An enteric virus can replace the beneficial function of commensal bacteria. Nature 516, 94-98. |
56 | Kim, J. I., Lee, I., Park, S., Hwang, M. W., Bae, J. Y., Lee, S., Heo, J., Park, M. S., Garcia-Sastre, A. and Park, M. S. (2013) Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution. J. Virol. 87, 7539-7549. DOI |
57 | Kluver, E., Schulz, A., Forssmann, W. G. and Adermann, K. (2002) Chemical synthesis of beta-defensins and LEAP-1/hepcidin. J. Pept. Res. 59, 241-248. DOI |
58 | Wiens, M. E. and Smith, J. G., (2015) Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection. J. Virol. 89, 2866-2874. DOI |
59 | Wiens, M. E. and Smith, J. G., (2017) a-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome. mBio 8, e02304-16. |
60 | Wiens, M. E., Wilson, S. S., Lucero, C. M. and Smith, J. G. (2014) Defensins and viral infection: dispelling common misconceptions. PLoS Pathog. 10, e1004186. DOI |
61 | Wilson, S. S., Wiens, M. E., Holly, M. K. and Smith, J. G. (2016) Defensins at the mucosal surface: latest insights into defensin-virus interactions. J. Virol. 90, 5216-5218. DOI |
62 | Wilson, S. S., Wiens, M. E. and Smith, J. G. (2013) Antiviral mechanisms of human defensins. J. Mol. Biol. 425, 4965-4980. DOI |
63 | Raj, P. A., Antonyraj, K. J. and Karunakaran, T. (2000) Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem. J. 347 Pt 3, 633-641. DOI |
64 | Pone, E. J., Xu, Z., White, C. A., Zan, H. and Casali, P. (2012) B cell TLRs and induction of immunoglobulin class-switch DNA recombination. Front. Biosci. (Landmark Ed.) 17, 2594-2615. DOI |
65 | Proud, D., Sanders, S. P. and Wiehler, S. (2004) Human rhinovirus infection induces airway epithelial cell production of human betadefensin 2 both in vitro and in vivo. J. Immunol. 172, 4637-4645. DOI |
66 | Quinones-Mateu, M. E., Lederman, M. M., Feng, Z., Chakraborty, B., Weber, J., Rangel, H. R., Marotta, M. L., Mirza, M., Jiang, B., Kiser, P., Medvik, K., Sieg, S. F. and Weinberg, A. (2003) Human epithelial -defensins 2 and 3 inhibit HIV-1 replication. AIDS 17, F39-F48. DOI |
67 | Rapista, A., Ding, J., Benito, B., Lo, Y. T., Neiditch, M. B., Lu, W. and Chang, T. L. (2011) Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment. Retrovirology 8, 45. DOI |
68 | Roberts, J. N., Graham, B. S., Karron, R. A., Munoz, F. M., Falsey, A. R., Anderson, L. J., Marshall, V., Kim, S. and Beeler, J. A. (2016) Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop. Vaccine 34, 4843-4849. DOI |
69 | Rohrl, J., Yang, D., Oppenheim, J. J. and Hehlgans, T. (2010a) Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J. Immunol. 184, 6688-6694. DOI |
70 | Pica, N. and Palese, P. (2013) Toward a universal influenza virus vaccine: prospects and challenges. Annu. Rev. Med. 64, 189-202. DOI |
71 | Edfeldt, K., Liu, P. T., Chun, R., Fabri, M., Schenk, M., Wheelwright, M., Keegan, C., Krutzik, S. R., Adams, J. S., Hewison, M. and Modlin, R. L. (2010) T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. U.S.A. 107, 22593-22598. DOI |
72 | Dowd, K. A., Jost, C. A., Durbin, A. P., Whitehead, S. S. and Pierson, T. C. (2011) A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog. 7, e1002111. DOI |
73 | Dowd, K. A., Mukherjee, S., Kuhn, R. J. and Pierson, T. C. (2014) Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition. J. Virol. 88, 11726-11737. DOI |
74 | Dugan, A. S., Maginnis, M. S., Jordan, J. A., Gasparovic, M. L., Manley, K., Page, R., Williams, G., Porter, E., O'Hara, B. A. and Atwood, W. J. (2008) Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. J. Biol. Chem. 283, 31125-31132. DOI |
75 | Scott, L. J. (2016) Tetravalent dengue vaccine: a review in the prevention of dengue disease. Drugs 76, 1301-1312. DOI |
76 | Semple, F., MacPherson, H., Webb, S., Kilanowski, F., Lettice, L., Mc- Glasson, S. L., Wheeler, A. P., Chen, V., Millhauser, G. L., Melrose, L., Davidson, D. J. and Dorin, J. R. (2015) Human -defensin 3 [corrected] exacerbates MDA5 but suppresses TLR3 responses to the viral molecular pattern mimic polyinosinic:polycytidylic acid. PLoS Genet. 11, e1005673. DOI |
77 | Seo, E. S., Blaum, B. S., Vargues, T., De Cecco, M., Deakin, J. A., Lyon, M., Barran, P. E., Campopiano, D. J. and Uhrin, D. (2010) Interaction of human -defensin 2 (HBD2) with glycosaminoglycans. Biochemistry 49, 10486-10495. DOI |
78 | Uyangaa, E., Kim, J. H., Patil, A. M., Choi, J. Y., Kim, S. B. and Eo, S. K. (2015) Distinct upstream role of type I IFN signaling in hematopoietic stem cell-derived and epithelial resident cells for concerted Recruitment of Ly-6Chi monocytes and NK cells via CCL2-CCL3 cascade. PLoS Pathog. 11, e1005256. DOI |
79 | Hancock, R. E. and Diamond, G. (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8, 402-410. DOI |
80 | Tewary, P., de la Rosa, G., Sharma, N., Rodriguez, L. G., Tarasov, S. G., Howard, O. M., Shirota, H., Steinhagen, F., Klinman, D. M., Yang, D. and Oppenheim, J. J. (2013) -Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN- production by human plasmacytoid dendritic cells, and promote inflammation. J. Immunol. 191, 865-874. DOI |
81 | Vanheule, V., Vervaeke, P., Mortier, A., Noppen, S., Gouwy, M., Snoeck, R., Andrei, G., Van Damme, J., Liekens, S. and Proost, P. (2016) Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus. Biochem. Pharmacol. 100, 73-85. DOI |
82 | Vannice, K. S., Roehrig, J. T. and Hombach, J. (2015) Next generation dengue vaccines: a review of the preclinical development pipeline. Vaccine 33, 7091-7099. DOI |
83 | Vemula, S. V., Amen, O., Katz, J. M., Donis, R., Sambhara, S. and Mittal, S. K. (2013a) Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time. Virus Res. 178, 398-403. DOI |
84 | Vemula, S. V., Pandey, A., Singh, N., Katz, J. M., Donis, R., Sambhara, S. and Mittal, S. K. (2013b) Adenoviral vector expressing murine -defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice. Virus Res. 177, 55- 61. DOI |
85 | Wu, Z., Ericksen, B., Tucker, K., Lubkowski, J. and Lu, W. (2004) Synthesis and characterization of human alpha-defensins 4-6. J. Pept. Res. 64, 118-125. DOI |
86 | Wohlford-Lenane, C. L., Meyerholz, D. K., Perlman, S., Zhou, H., Tran, D., Selsted, M. E. and McCray, P. B., Jr. (2009) Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease. J. Virol. 83, 11385-11390. DOI |
87 | Woo, J. I., Kil, S. H., Brough, D. E., Lee, Y. J., Lim, D. J. and Moon, S. K. (2015) Therapeutic potential of adenovirus-mediated delivery of -defensin 2 for experimental otitis media. Innate Immun. 21, 215-224. DOI |
88 | Wu, Z., Cocchi, F., Gentles, D., Ericksen, B., Lubkowski, J., Devico, A., Lehrer, R. I. and Lu, W. (2005) Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro. FEBS Lett. 579, 162-166. DOI |
89 | Sittisombut, N., Maneekarn, N., Kanjanahaluethai, A., Kasinrerk, W., Viputtikul, K. and Supawadee, J. (1995) Lack of augmenting effect of interferon-gamma on dengue virus multiplication in human peripheral blood monocytes. J. Med. Virol. 45, 43-49. DOI |
90 | Sharadadevi, A. and Nagaraj, R. (2010) A molecular dynamics study of human defensins HBD-1 and HNP-3 in water. J. Biomol. Struct. Dyn. 27, 541-550. DOI |
91 | Smith, J. G. and Nemerow, G. R. (2008) Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe 3, 11- 19. DOI |
92 | Smith, J. G., Silvestry, M., Lindert, S., Lu, W., Nemerow, G. R. and Stewart, P. L. (2010) Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog. 6, e1000959. DOI |
93 | Suarez-Carmona, M., Hubert, P., Delvenne, P. and Herfs, M. (2015) Defensins: "Simple" antimicrobial peptides or broad-spectrum molecules? Cytokine Growth Factor Rev. 26, 361-370. DOI |
94 | Herrera, R., Morris, M., Rosbe, K., Feng, Z., Weinberg, A. and Tugizov, S. (2016) Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells. Virology 487, 172-187. DOI |
95 | Hartshorn, K. L., White, M. R., Tecle, T., Holmskov, U. and Crouch, E. C. (2006) Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J. Immunol. 176, 6962-6972. DOI |
96 | Hazrati, E., Galen, B., Lu, W., Wang, W., Ouyang, Y., Keller, M. J., Lehrer, R. I. and Herold, B. C. (2006) Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J. Immunol. 177, 8658-8666. DOI |
97 | Heapy, A. M., Williams, G. M., Fraser, J. D. and Brimble, M. A. (2012) Synthesis of a dicarba analogue of human beta-defensin-1 using a combined ring closing metathesis--native chemical ligation strategy. Org. Lett. 14, 878-881. DOI |
98 | Hill, D. A., Baron, S. and Chanock, R. M. (1969) The effect of an interferon inducer on influenza virus. Bull. World Health Organ. 41, 689-693. |
99 | Hokeness, K. L., Kuziel, W. A., Biron, C. A. and Salazar-Mather, T. P. (2005) Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174, 1549-1556. DOI |
100 | Hoover, D. M., Chertov, O. and Lubkowski, J. (2001) The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J. Biol. Chem. 276, 39021-39026. DOI |
101 | Hoover, D. M., Wu, Z., Tucker, K., Lu, W. and Lubkowski, J. (2003) Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 47, 2804-2809. DOI |
102 | Jang, Y. H. and Seong, B. L. (2014) Options and obstacles for designing a universal influenza vaccine. Viruses 6, 3159-3180. DOI |
103 | Vos, Q., Lees, A., Wu, Z. Q., Snapper, C. M. and Mond, J. J. (2000) Bcell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176, 154-170. DOI |
104 | Wang, A., Chen, F., Wang, Y., Shen, M., Xu, Y., Hu, J., Wang, S., Geng, F., Wang, C., Ran, X., Su, Y., Cheng, T. and Wang, J. (2013) Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites. J. Virol. 87, 2835-2845. DOI |
105 | Watanabe, T., Watanabe, S., Maher, E. A., Neumann, G. and Kawaoka, Y. (2014) Pandemic potential of avian influenza A (H7N9) viruses. Trends Microbiol. 22, 623-631. DOI |
106 | Watford, W. T., Moriguchi, M., Morinobu, A. and O'Shea, J. J. (2003) The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14, 361-368. DOI |
107 | Weinberg, A., Quinones-Mateu, M. E. and Lederman, M. M. (2006) Role of human beta-defensins in HIV infection. Adv. Dent. Res. 19, 42-48. DOI |
108 | Wencker, M. and Brantly, M. L. (2005) Cytotoxic concentrations of alpha-defensins in the lungs of individuals with alpha 1-antitrypsin deficiency and moderate to severe lung disease. Cytokine 32, 1-6. DOI |
109 | LeMessurier, K. S., Lin, Y., McCullers, J. A. and Samarasinghe, A. E. (2016) Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice. Antiviral. Res. 133, 208-217. DOI |
110 | Leikina, E., Delanoe-Ayari, H., Melikov, K., Cho, M. S., Chen, A., Waring, A. J., Wang, W., Xie, Y., Loo, J. A., Lehrer, R. I. and Chernomordik, L. V. (2005) Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat. Immunol. 6, 995-1001. DOI |
111 | Li, W., Feng, Y., Kuang, Y., Zeng, W., Yang, Y., Li, H., Jiang, Z. and Li, M. (2014) Construction of eukaryotic expression vector with mBD1- mBD3 fusion genes and exploring its activity against influenza A virus. Viruses 6, 1237-1252. DOI |
112 | Liang, Z., Wu, S., Li, Y., He, L., Wu, M., Jiang, L., Feng, L., Zhang, P. and Huang, X. (2011) Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN- in cultured hepatoma cells. PLoS ONE 6, e23346. DOI |
113 | Mahanonda, R., Sa-Ard-Iam, N., Rerkyen, P., Thitithanyanont, A., Subbalekha, K. and Pichyangkul, S. (2012) MxA expression induced by -defensin in healthy human periodontal tissue. Eur. J. Immunol. 42, 946-956. DOI |
114 | White, M. R., Tecle, T., Crouch, E. C. and Hartshorn, K. L. (2007) Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L1293- L1299. DOI |
115 | Wie, S. H., Du, P., Luong, T. Q., Rought, S. E., Beliakova-Bethell, N., Lozach, J., Corbeil, J., Kornbluth, R. S., Richman, D. D. and Woelk, C. H. (2013) HIV downregulates interferon-stimulated genes in primary macrophages. J. Interferon Cytokine Res. 33, 90-95. DOI |
116 | Wiehler, S. and Proud, D. (2007) Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L505-L515. DOI |
117 | Machado, L. R. and Ottolini, B. (2015) An evolutionary history of defensins: a role for copy number variation in maximizing host innate and adaptive immune responses. Front. Immunol. 6, 115. |
118 | Mackewicz, C. E., Yuan, J., Tran, P., Diaz, L., Mack, E., Selsted, M. E. and Levy, J. A. (2003) Alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS 17, F23-F32. DOI |
119 | Mandal, M. and Nagaraj, R. (2002) Antibacterial activities and conformations of synthetic alpha-defensin HNP-1 and analogs with one, two and three disulfide bridges. J. Pept. Res. 59, 95-104. DOI |
120 | Yasin, B., Wang, W., Pang, M., Cheshenko, N., Hong, T., Waring, A. J., Herold, B. C., Wagar, E. A. and Lehrer R. I. (2004) Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J. Virol. 78, 5147-5156. DOI |
121 | Yeung, A. T., Gellatly, S. L. and Hancock, R. E. (2011) Multifunctional cationic host defence peptides and their clinical applications. Cell. Mol. Life Sci. 68, 2161-2176. DOI |
122 | Yin, L., Chino, T., Horst, O. V., Hacker, B. M., Clark, E. A., Dale, B. A. and Chung, W. O. (2010) Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria. BMC Immunol. 11, 37. DOI |
123 | Zhu, S. and Gao, B. (2013) Evolutionary origin of -defensins. Dev. Comp. Immunol. 39, 79-84. DOI |
124 | Zhu, W., Li, J. and Liang, G. (2011) How does cellular heparan sulfate function in viral pathogenicity? Biomed. Environ. Sci. 24, 81-87. |
125 | Bastian, A. and Schafer, H. (2001) Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul. Pept. 101, 157-161. DOI |
126 | Albanesi, C., Fairchild, H. R., Madonna, S., Scarponi, C., De Pita, O., Leung, D. Y. and Howell, M. D. (2007) IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J. Immunol. 179, 984-992. DOI |
127 | Alen, M. M., Dallmeier, K., Balzarini, J., Neyts, J. and Schols, D. (2012) Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection. Antiviral Res. 96, 280-287. DOI |
128 | Antcheva, N., Morgera, F., Creatti, L., Vaccari, L., Pag, U., Pacor, S., Shai, Y., Sahl, H. G. and Tossi, A. (2009) Artificial beta-defensin based on a minimal defensin template. Biochem. J. 421, 435-447. DOI |
129 | Nikfar, S., Rahimi, R. and Abdollahi, M. (2010) A meta-analysis of the efficacy and tolerability of interferon- in multiple sclerosis, overall and by drug and disease type. Clin. Ther. 32, 1871-1888. DOI |
130 | Nishimura, M., Abiko, Y., Kurashige, Y., Takeshima, M., Yamazaki, M., Kusano, K., Saitoh, M., Nakashima, K., Inoue, T. and Kaku, T. (2004) Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. J. Dermatol. Sci. 36, 87-95. DOI |
131 | Park, S., Kim, J. I., Lee, I., Bae, J. Y., Hwang, M. W., Kim, D., Jang, S. I., Kim, H., Park, M. S., Kwon, H. J., Song, J. W., Cho, Y. S., Chun, W. and Park, M. S. (2014) Inhibition of Pseudomonas aeruginosa with a recombinant RNA-based viral vector expressing human -defensin 4. BMC Microbiol. 14, 237. DOI |
132 | Openshaw, P. J. (2002) Potential therapeutic implications of new insights into respiratory syncytial virus disease. Respir Res. 3, S15- S20. DOI |
133 | Openshaw, P. J. and Tregoning, J. S. (2005) Immune responses and disease enhancement during respiratory syncytial virus infection. Clin. Microbiol. Rev. 18, 541-555. DOI |
134 | Park, M. S., Kim, J. I., Park, S., Lee, I. and Park, M. S. (2016) Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity. Immune Netw. 16, 261-270. DOI |
135 | Perron, G. G., Zasloff, M. and Bell, G. (2006) Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273, 251- 256. DOI |
136 | Perry, C. M. and Wilde, M. I. (1998) Interferon-alpha-2a: a review of its use in chronic hepatitis C. BioDrugs 10, 65-89. DOI |
137 | Phoenix, D. A., Dennison, S. R. and Harris, F. (2013) Antimicrobial peptides: their history, evolution, and functional promiscuity. In Antimicrobial Peptides, pp. 1-38. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. |
138 | Crack, L. R., Jones, L., Malavige, G. N., Patel, V. and Ogg, G. S. (2012) Human antimicrobial peptides LL-37 and human beta-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus. Clin. Exp. Dermatol. 37, 534-543. DOI |
139 | Chang, T. L., Vargas, J., Jr., DelPortillo, A. and Klotman, M. E. (2005) Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. 115, 765-773. DOI |
140 | Collins, P. L. and Melero, J. A. (2011) Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 162, 80-99. DOI |
141 | Crane, M. J., Hokeness-Antonelli, K. L. and Salazar-Mather, T. P. (2009) Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: role for type I interferons in localized induction of CCR2 ligands. J. Immunol. 183, 2810-2817. DOI |
142 | Daher, K. A., Selsted, M. E. and Lehrer, R. I. (1986) Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60, 1068- 1074. |
143 | de Leeuw, E., Burks, S. R., Li, X., Kao, J. P. and Lu, W. (2007) Structure- dependent functional properties of human defensin 5. FEBS Lett. 581, 515-520. DOI |
144 | De Paula, V. S., Pomin, V. H. and Valente, A. P. (2014) Unique properties of human -defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site. J. Biol. Chem. 289, 22969-22979. DOI |
145 | Flatt, J. W., Kim, R., Smith, J. G., Nemerow, G. R. and Stewart, P. L. (2013) An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS ONE 8, e61571. DOI |
146 | Eisenhauer, P. B. and Lehrer, R. I. (1992) Mouse neutrophils lack defensins. Infect. Immun. 60, 3446-3447. |
147 | Erwin, D. H. and Davidson, E. H. (2002) The last common bilaterian ancestor. Development 129, 3021-3032. |
148 | Ferguson, N. M., Rodriguez-Barraquer, I., Dorigatti, I., Mier, Y. T.-R. L., Laydon, D. J. and Cummings, D. A. (2016) Benefits and risks of the Sanofi-Pasteur dengue vaccine: modeling optimal deployment. Science 353, 1033-1036. DOI |
149 | Rohrl, J., Yang, D., Oppenheim, J. J. and Hehlgans, T. (2010b) Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J. Biol. Chem. 285, 7028-7034. DOI |
150 | Demirkhanyan, L., Marin, M., Lu, W. and Melikyan, G. B. (2013) Subinhibitory concentrations of human -defensin potentiate neutralizing antibodies against HIV-1 gp41 pre-hairpin intermediates in the presence of serum. PLoS Pathog. 9, e1003431. DOI |
151 | Rothman, A. L. (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 11, 532-543. DOI |
152 | Ryan, L. K., Dai, J., Yin, Z., Megjugorac, N., Uhlhorn, V., Yim, S., Schwartz, K. D., Abrahams, J. M., Diamond, G. and Fitzgerald-Bocarsly, P. (2011) Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity. J. Leukoc. Biol. 90, 343-356. DOI |
153 | Ryan, L. K., Diamond, G., Amrute, S., Feng, Z., Weinberg, A. and Fitzgerald-Bocarsly, P. (2003) Detection of HBD1 peptide in peripheral blood mononuclear cell subpopulations by intracellular flow cytometry. Peptides 24, 1785-1794. DOI |
154 | Saitoh, T., Komano, J., Saitoh, Y., Misawa, T., Takahama, M., Kozaki, T., Uehata, T., Iwasaki, H., Omori, H., Yamaoka, S., Yamamoto, N. and Akira, S. (2012) Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe 12, 109-116. DOI |
155 | Salvatore, M., Garcia-Sastre, A., Ruchala, P., Lehrer, R. I., Chang, T. and Klotman, M. E. (2007) alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J. Infect. Dis. 196, 835- 843. DOI |
156 | Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F. and Lehrer, R. I. (1985) Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76, 1427-1435. DOI |
157 | Fox, J. L. (2013) Antimicrobial peptides stage a comeback. Nat. Biotechnol. 31, 379-382. DOI |
158 | Furci, L., Tolazzi, M., Sironi, F., Vassena, L. and Lusso, P. (2012) Inhibition of HIV-1 infection by human -defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae. PLoS ONE 7, e45208. DOI |
159 | Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720. DOI |
160 | Gao, X. F., Yang, Z. W. and Li, J. (2011) Adjunctive therapy with interferon- gamma for the treatment of pulmonary tuberculosis: a systematic review. Int. J. Infect. Dis. 15, e594-e600. DOI |
161 | Garcia, A. E., Osapay, G., Tran, P. A., Yuan, J. and Selsted, M. E. (2008) Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect. Immun. 76, 5883-5891. DOI |
162 | Sun, L., Finnegan, C. M., Kish-Catalone, T., Blumenthal, R., Garzino- Demo, P., La Terra Maggiore, G. M., Berrone, S., Kleinman, C., Wu, Z., Abdelwahab, S., Lu, W. and Garzino-Demo, A. (2005) Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J. Virol. 79, 14318-14329. DOI |
163 | Surasombatpattana, P., Hamel, R., Patramool, S., Luplertlop, N., Thomas, F., Despres, P., Briant, L., Yssel, H. and Misse, D. (2011) Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect. Genet. Evol. 11, 1664-1673. DOI |
164 | Tecle, T., White, M. R., Gantz, D., Crouch, E. C. and Hartshorn, K. L. (2007) Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J. Immunol. 178, 8046-8052. DOI |
165 | Savelkoul, H. F., Ferro, V. A., Strioga, M. M. and Schijns, V. E. (2015) Choice and design of adjuvants for parenteral and mucosal vaccines. Vaccines (Basel) 3, 148-171. DOI |
166 | Schutte, B. C., Mitros, J. P., Bartlett, J. A., Walters, J. D., Jia, H. P., Welsh, M. J., Casavant, T. L. and McCray, P. B., Jr. (2002) Discovery of five conserved beta -defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. U.S.A. 99, 2129-2133. DOI |
167 | Swanson, C. L., Wilson, T. J., Strauch, P., Colonna, M., Pelanda, R. and Torres, R. M. (2010) Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J. Exp. Med. 207, 1485-1500. DOI |
168 | Szyk, A., Wu, Z., Tucker, K., Yang, D., Lu, W. and Lubkowski, J. (2006) Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci. 15, 2749-2760. DOI |
169 | Tate, M. D., Job, E. R., Deng, Y. M., Gunalan, V., Maurer-Stroh, S. and Reading, P. C. (2014) Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses 6, 1294-1316. DOI |
170 | Tenge, V. R., Gounder, A. P., Wiens, M. E., Lu, W. and Smith, J. G. (2014) Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition. PLoS Pathog. 10, e1004360. DOI |